‘We do not want humans to have the same fate as dinosaurs’: SpaceX IPO reads like Hollywood fantasy version of the future

SpaceX disclosed a $2.6 billion operating loss on $18.7 billion of revenue last year, while the company is preparing a large public share sale that reports value around $75 billion. The filing also said xAI lost $6.4 billion in operations last year, though Starlink generated $4.4 billion of operating income and remains a major cash source. The prospectus highlights unusually ambitious valuation and control terms, including stock awards tied to a $7.5 trillion market cap and a permanent human colony on Mars.

Analysis

The market should read this less as a clean IPO story and more as a financing and control event. A listing of this scale would create a new public-market benchmark for “strategic monopoly plus moonshot optionality,” but the embedded governance structure means minority holders are effectively underwriting growth with almost no influence over capital allocation, related-party transfers, or follow-on acquisitions. That combination tends to compress the investor base to crossover funds willing to treat this as a momentum/brand trade rather than a normal fundamental ownership case.

The bigger second-order issue is capital gravity: if this raises anywhere near the reported size, it could become the funding source for a multi-year ecosystem of space, AI, and infrastructure projects that competes directly with better-capitalized public peers. The article suggests a profitable cash engine in satellite connectivity, but the use of those cash flows to subsidize unproven adjacencies raises the probability of future cross-subsidization and internal capital allocation distortions. That is bearish for standalone valuation discipline across private-market aerospace/defense and high-growth AI infrastructure names, because investors may start demanding proof of self-funding rather than narrative-driven TAM expansion.

The near-term catalyst path is binary: pricing, first lockup/road-show demand, and any disclosure around related-party governance. Over the next few days, expect volatility around whether investors focus on the profitable network effects in communications or on the conglomerate structure and loss-making adjacent businesses. Over months, the key risk is political and procurement scrutiny: if federal contract dependence becomes a headline, the multiple can re-rate downward quickly because the market will start discounting renewal risk and ethics risk together.

Contrarian view: the consensus is likely overestimating how much the market will penalize losses and underestimating the scarcity premium for a globally scaled, geopolitically relevant infrastructure asset with recurring revenue. If the book is dominated by long-only growth and sovereign capital, the stock may trade more like a strategic utility than a speculative issuer. The upside is not in near-term earnings quality; it is in the possibility that public investors decide they want exposure to a vertically integrated space platform before the next wave of defense and orbital infrastructure spending hits the budget cycle.

Key Decisions for Investors

• Avoid chasing any first-day pop in the new listing; wait for the post-roadshow book to clear and for lockup/allocations to normalize. Risk/reward is poor in the first 1-2 sessions because the float, governance, and demand mix will be unstable.
• Long private-market space-adjacent defense infrastructure where execution is cleaner than the headline name; prefer ORB/PL-type exposure only if valuation resets lower on sympathy selloffs. The trade works if public-market investors rotate away from complexity and re-rate pure-play cash flows upward over 1-3 months.
• Short a basket of highly levered, narrative-driven AI infrastructure or deep-tech names that rely on perpetual external funding if this IPO becomes the new “benchmark” for funding scale. If capital markets get more skeptical of loss-making adjacencies, these names can underperform by 10-20% over 1-2 quarters.
• Use options to express a volatility view rather than a directional one: buy 60-90 day straddles/strangles on any public comps that are likely to move on the deal headline. The catalyst stack is crowded and the implied move should be underpriced if the market is still digesting governance and political risk.
• Watch federal-procurement-sensitive contractors for a relative-value short if scrutiny around contract awards intensifies. A pair like short a government-contract-heavy aerospace prime versus long a higher-quality defense software name can capture any rerating away from ethics/renewal risk over the next 3-6 months.